Adaptation and selection shape clonal evolution of tumors during residual disease and recurrenceAndrea Walens, James V. Alvarez, Jiaxing Lin et al.|Nature Communications|2020Cited by 52
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Mariaelena Pierobon et al.|Nature Cancer|2022Cited by 42
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cellsJillian Hattaway Luttman, Ann Marie Pendergast, Jacob P. Hoj et al.|Cell Reports|2021Cited by 18
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Kouros Owzar, Chen Jiang et al.|Scientific Reports|2018Cited by 17
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X. Ang, Kris C. Wood, Natalia Sutiman et al.|Proceedings of the National Academy of Sciences|2023Cited by 16